PCDC EDRN-APaCC Joint (Virtual) Meeting

Meeting Date and Time
-
Location
Virtual via WebEx
Speaker(s)
Various
Sponsor(s)
PCDC
EDRN-APaCC
Major Program
Pancreatic Cancer Detection Consortium
Research Group
Early Detection

Date Posted

The National Cancer Institute’s Pancreatic Cancer Detection Consortium (PCDC) and Early Detection Research Network – Alliance of Pancreatic Cancer Consortia for Early Detection (EDRN– APaCC) Joint (Virtual) Meeting

DRAFT Agenda

All times are Eastern Standard Time

Time Session Title / Speaker(s) / Affiliation(s)
10:30 a.m.–1:00 p.m. Opening Session

Moderator
Sharmistha Ghosh-Janjigian, Ph.D.
Program Director, Cancer Biomarkers Research Group (CBRG), Division of Cancer Prevention (DCP), NCI
10:30–10:35 a.m. Call the Meeting to Order

Brian Wolpin, M.D.
Dana Farber Cancer Institute/Harvard Medical School, PCDC Steering Committee Co-Chair

Walter Park, M.D.
Stanford University, PCDC Steering Committee Co-Chair
10:35–11:00 a.m. Biomarkers for Early Detection of Pancreatic Cancer: It Takes a Village

Sudhir Srivastava, Ph.D., M.P.H.
Chief, CBRG, DCP, NCI
11:00–11:45 a.m. Keynote Talk 1: IMMray PanCan-d, a Multiplex Serum Biomarker Assay for the Detection of Early Stage Pancreatic Ductal Adenocarcinoma

Thomas King, M.D.
Medical Officer, Immunovia
11:45 a.m.–12:45 p.m. Overview of PCDC Scientific Research

Brian Wolpin, M.D.
DFCI, HMS

Walter Park, M.D.
Stanford University
12:45–1:00 p.m. Q&A Session
1:00–1:20 p.m. Break
1:20–3:40 p.m. Overview of Cohort Studies

Moderators
Michael Goggins, M.D.
Johns Hopkins

Rosalie Sears, Ph.D.
Oregon Health & Science University
1:20–1:50 p.m. Keynote Talk 2: Pancreatic Cysts: A Modifiable Risk Factor for Pancreatic Cancer – Research Challenges in EA2185

Peter O’Dwyer, M.D. 
University of Pennsylvania
1:50–2:10 p.m. Overview of PCDC Phase 2 and Phase 3 Cohorts

Gloria Petersen, Ph.D.
Mayo Clinic, Rochester, MN

William Bamlet, M.S. 
Mayo Clinic, Rochester, MN
2:10–2:30 p.m. Overview of EDRN Cohorts

Randy Brand, M.D.
University of Pittsburgh
2:30–2:50 p.m. Overview of Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) Cohorts

Stephen Pandol, M.D.
University of California, Los Angeles
2:50–3:10 p.m. Overview of Kaiser Permanente Cohorts

Bechien U. Wu, M.D. 
Kaiser Permanente Southern California
3:10–3:40 p.m. Q&A and Discussion Session
3:40–4:00 p.m. Break
4:00–4:30 p.m. Applying Artificial Intelligence to Electronic Health Records

Moderators
Barbara Kenner, Ph.D.
Kenner Family Research Fund

Matthew Young, Ph.D. 
Program Director, NCI

Pancreatic Cancer Risk Prediction from Disease Trajectories Using Deep Learning

Chris Sander, Ph.D.
Dana-Farber Cancer Institute, HMS
4:30–4:45 p.m. Q&A Session
4:45-5:30 p.m. Collaborative Social

Brainstorming Session – New Collaborations and Setting Tangible Goals (Emphasis on Discovery/Development)

Moderators
Dan Von Hoff, M.D., F.A.C.P.
TGen

Anirban Maitra, M.B.B.S. 
MD Anderson

Discussants
  • Pratip Bhattacharya, Ph.D. (MD Anderson)
  • Sharmistha Ghosh-Janjigian, Ph.D. (NCI)
  • Tony Hollingsworth, Ph.D. (U Nebraska Med Center)
  • Florencia McAllister, M.D. (MD Anderson)
  • Guillermo Marquez, Ph.D. (Program Director, NCI)
  • Gloria Petersen, Ph.D. (Mayo Clinic)
  • Jo Ann Rinaudo, Ph.D. (Program Director, NCI)
  • Sudhir Srivastava, Ph.D., M.P.H. (Chief, CBRG, DCP)
  • Brian Wolpin, M.D. (DFCI, HMS)
  • Matthew Young, Ph.D. (NCI)
Discussion topics can include:
  • Partnership with industry – when to collaborate
  • Identifying trans-cohort collaborative efforts
  • Expediting discovery and developing CLIA certified and FDA approved biomarker tests
5:30 p.m. Adjourn

Contact Name

Juan Miguel Villanueva
juan.villanueva@nih.gov